Arkolith/Funds/Lilly Endowment Inc

Lilly Endowment Inc

CIK 316011Endowment / foundation
Holdings as of Mar 31, 2026·disclosed Apr 20, 2026·~20-day 13F lag·13F-HR
Inactive

Lilly Endowment Inc holds a concentrated book of 1 stock worth $84.5B as of Q1 2026 (disclosed Apr 20, 2026, a ~45-day 13F lag). This quarter they trimmed Eli Lilly & Co. Their largest long position is Eli Lilly & Co at 100% of the equity book.

Build

Build on this 13F portfolio

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp
Build

Ask your agent what Lilly Endowment Inc owns

This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.

Get a key Compare plans13F data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/funds/316011/holdings"
Ask your agent
Use Arkolith to show LILLY ENDOWMENT INC's latest
holdings, largest changes, and filing provenance.
Opened
0
new positions
Added to
0
existing
Trimmed
1
reduced
Sold out
0
exited

Concentration

Top-heavy: concentrated book

Top 5 holdings
100%
Top 10 holdings
100%
Top 20 holdings
100%

Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.

Direct sector allocation

100% mapped to company sectors

Health Care
100%

Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.

Biggest moves: latest quarter

Estimated $ traded · quarter-end prices, no cost basis

Bought

No buys this quarter.

Trimmed / exited

Holdings: largest first

Bars show each stock's share of the portfolio. Click a row for its position history.

1 positions
#SecurityValueShares% PortLast moveHistory
1Eli Lilly and Company
Common
$84.5B91.90M
100.0%
▼−0.3%
Reduced · −294K sh
Showing all 1 positions

Filing history

As-of date vs the date the SEC received each filing

QuarterAs ofFiledPositionsValueForm
Q1 2026Mar 31, 2026Apr 20, 20261$84.5B13F-HR
Q4 2025Dec 31, 2025Jan 23, 20261$99.1B13F-HR
Q3 2025Sep 30, 2025Oct 31, 20251$72.9B13F-HR
Q2 2025Jun 30, 2025Jul 10, 20251$74.8B13F-HR
Q1 2025Mar 31, 2025Apr 16, 20251$79.3B13F-HR
Q4 2024Dec 31, 2024Jan 27, 20251$74.8B13F-HR
Q3 2024Sep 30, 2024Oct 3, 20241$85.8B13F-HR
Q2 2024Jun 30, 2024Jul 16, 20241$88.2B13F-HR
Q1 2024Mar 31, 2024Apr 16, 20241$76.9B13F-HR
Q4 2023Dec 31, 2023Jan 25, 20241$58.2B13F-HR
Q3 2023Sep 30, 2023Oct 12, 20231$53.7B13F-HR
Q2 2023Jun 30, 2023Jul 10, 20231$47.4B13F-HR
Q1 2023Mar 31, 2023Apr 17, 20231$35.2B13F-HR
Q4 2022Dec 31, 2022Jan 26, 20231$37.7B13F-HR
Q3 2022Sep 30, 2022Oct 5, 20221$33.6B13F-HR
Q2 2022Jun 30, 2022Jul 18, 20221$33.8B13F-HR
Q1 2022Mar 31, 2022Apr 19, 20221$30.4B13F-HR
Q4 2021Dec 31, 2021Jan 27, 20221$29.7B13F-HR
Q3 2021Sep 30, 2021Oct 8, 20211$25.0B13F-HR
Q2 2021Jun 30, 2021Jul 19, 20211$25.1B13F-HR
Q1 2021Mar 31, 2021Apr 12, 20211$20.6B13F-HR
Q4 2020Dec 31, 2020Jan 21, 20211$18.8B13F-HR
Q3 2020Sep 30, 2020Oct 5, 20201$16.4B13F-HR
Q2 2020Jun 30, 2020Jul 16, 20201$18.3B13F-HR

Data source

Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.